These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22666496)

  • 41. Genome-wide association of lipid-lowering response to statins in combined study populations.
    Barber MJ; Mangravite LM; Hyde CL; Chasman DI; Smith JD; McCarty CA; Li X; Wilke RA; Rieder MJ; Williams PT; Ridker PM; Chatterjee A; Rotter JI; Nickerson DA; Stephens M; Krauss RM
    PLoS One; 2010 Mar; 5(3):e9763. PubMed ID: 20339536
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Low-density lipoprotein size, pravastatin treatment, and coronary events.
    Campos H; Moye LA; Glasser SP; Stampfer MJ; Sacks FM
    JAMA; 2001 Sep; 286(12):1468-74. PubMed ID: 11572739
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Are the WOSCOPS clinical and economic findings generalizable to other populations? A case study for Belgium. The WOSCOPS Economic Analysis Group. West of Scotland Coronary Prevention Study.
    Caro JJ; Huybrechts KF; De Backer G; De Bacquer D; Closon MC
    Acta Cardiol; 2000 Aug; 55(4):239-46. PubMed ID: 11041122
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A polymorphism of the cholesteryl ester transfer protein gene predicts cardiovascular events in non-smokers in the West of Scotland Coronary Prevention Study.
    Freeman DJ; Samani NJ; Wilson V; McMahon AD; Braund PS; Cheng S; Caslake MJ; Packard CJ; Gaffney D
    Eur Heart J; 2003 Oct; 24(20):1833-42. PubMed ID: 14563342
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genetic variation at the SLCO1B1 gene locus and low density lipoprotein cholesterol lowering response to pravastatin in the elderly.
    Akao H; Polisecki E; Kajinami K; Trompet S; Robertson M; Ford I; Jukema JW; de Craen AJ; Westendorp RG; Shepherd J; Packard C; Buckley BM; Schaefer EJ
    Atherosclerosis; 2012 Feb; 220(2):413-7. PubMed ID: 22189199
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetic risk prediction and a 2-stage risk screening strategy for coronary heart disease.
    Tikkanen E; Havulinna AS; Palotie A; Salomaa V; Ripatti S
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2261-6. PubMed ID: 23599444
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of pravastatin on mortality in patients with and without coronary heart disease across a broad range of cholesterol levels. The Prospective Pravastatin Pooling project.
    Simes J; Furberg CD; Braunwald E; Davis BR; Ford I; Tonkin A; Shepherd J
    Eur Heart J; 2002 Feb; 23(3):207-15. PubMed ID: 11792135
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Atorvastatin: its clinical role in cerebrovascular prevention.
    Gaspardone A; Arca M
    Drugs; 2007; 67 Suppl 1():55-62. PubMed ID: 17910521
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pravastatin for cardiovascular event primary prevention in patients with mild-to-moderate hypertension in the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA) Study.
    Kushiro T; Mizuno K; Nakaya N; Ohashi Y; Tajima N; Teramoto T; Uchiyama S; Nakamura H;
    Hypertension; 2009 Feb; 53(2):135-41. PubMed ID: 19104004
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Screening experience and baseline characteristics in the West of Scotland Coronary Prevention Study. The WOSCOPS Study Group. West of Scotland Coronary Prevention Study.
    Am J Cardiol; 1995 Sep; 76(7):485-91. PubMed ID: 7653449
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A comparison of economic modelling and clinical trials in the economic evaluation of cholesterol-modifying pharmacotherapy.
    Morris S
    Health Econ; 1997; 6(6):589-601. PubMed ID: 9466141
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Statin Use is Not Associated with Future Long-Term Care Admission: Extended Follow-Up of Two Randomised Controlled Trials.
    Burton JK; Papworth R; Haig C; McCowan C; Ford I; Stott DJ; Quinn TJ
    Drugs Aging; 2018 Jul; 35(7):657-663. PubMed ID: 29916140
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Factors affecting low-density lipoprotein and high-density lipoprotein cholesterol response to pravastatin in the West Of Scotland Coronary Prevention Study (WOSCOPS).
    Streja L; Packard CJ; Shepherd J; Cobbe S; Ford I;
    Am J Cardiol; 2002 Oct; 90(7):731-6. PubMed ID: 12356386
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Coronary heart disease in patients with low LDL-cholesterol: benefit of pravastatin in diabetics and enhanced role for HDL-cholesterol and triglycerides as risk factors.
    Sacks FM; Tonkin AM; Craven T; Pfeffer MA; Shepherd J; Keech A; Furberg CD; Braunwald E
    Circulation; 2002 Mar; 105(12):1424-8. PubMed ID: 11914249
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacogenetic study of statin therapy and cholesterol reduction.
    Chasman DI; Posada D; Subrahmanyan L; Cook NR; Stanton VP; Ridker PM
    JAMA; 2004 Jun; 291(23):2821-7. PubMed ID: 15199031
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A prospective study of pravastatin in the elderly at risk: new hope for older persons.
    Shepherd J
    Am J Geriatr Cardiol; 2004; 13(3 Suppl 1):17-24. PubMed ID: 15133425
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Clinical study of the month. The ALLHAT-LLT trial].
    Kulbertus H; Scheen AJ
    Rev Med Liege; 2003 Jan; 58(1):53-8. PubMed ID: 12647600
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Statin therapy in the elderly: does it make good clinical and economic sense?
    Mungall MM; Gaw A; Shepherd J
    Drugs Aging; 2003; 20(4):263-75. PubMed ID: 12641482
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of pravastatin therapy on coronary events in carriers of the KIF6 719Arg allele from the cholesterol and recurrent events trial.
    Shiffman D; Sabatine MS; Louie JZ; Kirchgessner TG; Iakoubova OA; Campos H; Devlin JJ; Sacks FM
    Am J Cardiol; 2010 May; 105(9):1300-5. PubMed ID: 20403483
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term risk stratification for survivors of acute coronary syndromes. Results from the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Study. LIPID Study Investigators.
    Marschner IC; Colquhoun D; Simes RJ; Glasziou P; Harris P; Singh BB; Friedlander D; White H; Thompson P; Tonkin A;
    J Am Coll Cardiol; 2001 Jul; 38(1):56-63. PubMed ID: 11451296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.